SCHEMBL5161530

SCHEMBL5161530

CC(=O)Oc1cc2c(cc1C(=O)O)[C@H]1CC[C@]3(C)C(=O)CC[C@H]3[C@@H]1CC2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 8/20 0.60
HSD17B1 P14061 7/20 0.60
ESR1 P03372 2/20 0.60
STS P08842 8/20 0.60
CYP3A4 P08684 2/20 0.57
LMNA P02545 2/20 0.57
MAPT P10636 2/20 0.57
AKR1B10 O60218 1/20 0.57
SHBG P04278 1/20 0.57
CYP1A2 P05177 1/20 0.57
PGR P06401 1/20 0.57
SERPINA6 P08185 1/20 0.57
AR P10275 1/20 0.57
AKR1B1 P15121 1/20 0.57
NFKB1 P19838 1/20 0.57
SLC6A4 P31645 1/20 0.57
OPRM1 P35372 1/20 0.57
SNCA P37840 1/20 0.57
HTR2B P41595 1/20 0.57
BLM P54132 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5158985 0.90 HSD17B1 (0.61) CYP19A1HSD17B1ESR1STSCYP3A4
SCHEMBL29169376 0.90 HSD17B1 (0.72) CYP19A1HSD17B1ESR1STSCYP3A4
SCHEMBL29169374 0.90 HSD17B1 (0.72) CYP19A1HSD17B1ESR1STSCYP3A4
SCHEMBL19688370 0.90 HSD17B1 (0.72) CYP19A1HSD17B1ESR1STSCYP3A4
SCHEMBL6266355 0.87 STS (0.70) CYP19A1HSD17B1ESR1STSCYP3A4
SCHEMBL6265194 0.87 STS (0.70) CYP19A1HSD17B1ESR1STSCYP3A4
SCHEMBL1234807 0.86 STS (0.71) CYP19A1HSD17B1ESR1STSCYP3A4
SCHEMBL5158357 0.85 CYP19A1 (0.71) CYP19A1HSD17B1ESR1STSCYP3A4
SCHEMBL30804206 0.83 CYP19A1 (0.71) CYP19A1HSD17B1ESR1STSCYP3A4
SCHEMBL9236798 0.82 CYP19A1 (0.73) CYP19A1HSD17B1ESR1STSCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1405860-B1 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use STANFORD RES INST INT (US) 2007-02-14 EP disclosed
EP-1405860-A1 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use SRI INTERNATIONAL (US) 2004-04-07 EP disclosed
EP-1042354-B1 ESTRONE SULFAMATE INHIBITORS OF ESTRONE SULFATASE, AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE STANFORD RES INST INT (US) 2004-03-03 EP disclosed
EP-1042354-A2 ESTRONE SULFAMATE INHIBITORS OF ESTRONE SULFATASE, AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE SRI INTERNATIONAL (US) 2000-10-11 EP disclosed
US-6046186-A ANTITUMOR AGENTS, ANTICARCINOGENIC AGENTS SRI INTERNATIONAL (US) 2000-04-04 US disclosed
WO-1999033858-A9 ESTRONE SULFAMATE INHIBITORS OF ESTRONE SULFATASE, AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE STANFORD RES INST INT (US) 1999-10-28 WO disclosed
WO-1999033858-A2 ESTRONE SULFAMATE INHIBITORS OF ESTRONE SULFATASE, AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE SRI INTERNATIONAL (US) 1999-07-08 WO disclosed